Chronic Telogen Effluvium: A Study of 5 Patients Over 7 Years

    Rodney Sinclair
    Image of study
    TLDR Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.
    The study followed five women diagnosed with chronic telogen effluvium (CTE), observing them for a minimum of 7 years. Four of the patients experienced ongoing hair shedding without a visible reduction in hair density or follicular miniaturization, suggesting that CTE may not necessarily progress to female pattern hair loss (FPHL). One patient developed FPHL, which partially reversed with spironolactone treatment. The study highlights the difficulty in differentiating CTE from FPHL due to variability in scalp biopsy specimens and recommends using three side-by-side punch biopsy specimens with horizontal sections for better diagnostic accuracy. The study concludes that further research is needed to understand the natural history of CTE and its potential progression to FPHL, as well as to determine the effectiveness of treatments like spironolactone in CTE, which currently lacks evidence.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 229 results

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community 2Y 5M on dut, ask me anything

      in Finasteride/Dutasteride  130 upvotes 2 months ago
      A user experienced significant hair regrowth using dutasteride without side effects, starting with finasteride and not using minoxidil or dermarolling. They attributed success to a unique genetic response to DHT blockers but did not share their full regimen, frustrating others.

      community 21, female, diagnosed with MPB. What do I do?

      in Female  15 upvotes 9 years ago
      A 21-year-old woman diagnosed with male pattern baldness (MPB) who is considering treatments such as spironolactone, minoxidil and finasteride to address her hair loss. The user also discusses potential solutions for concealing the appearance of her thinning hair, such as wigs or haircuts.

    Related Research

    6 / 6 results